| 发明名称 |
Crystal modification of 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide and use thereof |
| 摘要 |
The specification describes the modification A or A' of the compound 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide of formula (I), its use for the treatment of epilepsy, and pharmaceutical preparations comprising this crystal modification.
|
| 申请公布号 |
NZ331371(A) |
申请公布日期 |
2000.08.25 |
| 申请号 |
NZ19980331371 |
申请日期 |
1998.06.08 |
| 申请人 |
NOVARTIS AG |
发明人 |
PORTMANN, ROBERT;HOFMEIER, URS CHRISTOPH;BURKHARD, ANDREAS;SCHERRER, WALTER;SZELAGIEWICZ, MARTIN |
| 分类号 |
A61K31/41;A61K31/4192;A61P25/08;C07D249/04;(IPC1-7):C07D249/04;A61K31/00 |
主分类号 |
A61K31/41 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
